» Articles » PMID: 31884528

Modulation of Hypercapnic Respiratory Response by Cholinergic Transmission in the Commissural Nucleus of the Solitary Tract

Overview
Journal Pflugers Arch
Specialty Physiology
Date 2019 Dec 30
PMID 31884528
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The nucleus of the solitary tract (NTS) is an important area of the brainstem that receives and integrates afferent cardiorespiratory sensorial information, including those from arterial chemoreceptors and baroreceptors. It was described that acetylcholine (ACh) in the commissural subnucleus of the NTS (cNTS) promotes an increase in the phrenic nerve activity (PNA) and antagonism of nicotinic receptors in the same region reduces the magnitude of tachypneic response to peripheral chemoreceptor stimulation, suggesting a functional role of cholinergic transmission within the cNTS in the chemosensory control of respiratory activity. In the present study, we investigated whether cholinergic receptor antagonism in the cNTS modifies the sympathetic and respiratory reflex responses to hypercapnia. Using an arterially perfused in situ preparation of juvenile male Holtzman rats, we found that the nicotinic antagonist (mecamylamine, 5 mM), but not the muscarinic antagonist (atropine, 5 mM), into the cNTS attenuated the hypercapnia-induced increase of hypoglossal activity. Furthermore, mecamylamine in the cNTS potentiated the generation of late-expiratory (late-E) activity in abdominal nerve induced by hypercapnia. None of the cholinergic antagonists microinjected in the cNTS changed either the sympathetic or the phrenic nerve responses to hypercapnia. Our data provide evidence for the role of cholinergic transmission in the cNTS, acting on nicotinic receptors, modulating the hypoglossal and abdominal responses to hypercapnia.

Citing Articles

Hypoxic and Hypercapnic Responses in Transgenic Murine Model of Alzheimer's Disease Overexpressing Human AβPP: The Effects of Pretreatment with Memantine and Rivastigmine.

Andrzejewski K, Jampolska M, Mojzych I, Conde S, Kaczynska K Int J Mol Sci. 2022; 23(11).

PMID: 35682682 PMC: 9180806. DOI: 10.3390/ijms23116004.


The retrotrapezoid nucleus and the neuromodulation of breathing.

Moreira T, Sobrinho C, Falquetto B, Oliveira L, Lima J, Mulkey D J Neurophysiol. 2021; 125(3):699-719.

PMID: 33427575 PMC: 7988753. DOI: 10.1152/jn.00497.2020.

References
1.
Kubin L, Alheid G, Zuperku E, McCrimmon D . Central pathways of pulmonary and lower airway vagal afferents. J Appl Physiol (1985). 2006; 101(2):618-27. PMC: 4503231. DOI: 10.1152/japplphysiol.00252.2006. View

2.
Helke C, Handelmann G, Jacobowitz D . Choline acetyltransferase activity in the nucleus tractus solitarius: regulation by the afferent vagus nerve. Brain Res Bull. 1983; 10(4):433-6. DOI: 10.1016/0361-9230(83)90139-9. View

3.
Li A, Nattie E . Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle. J Physiol. 2010; 588(Pt 15):2935-44. PMC: 2956908. DOI: 10.1113/jphysiol.2010.191288. View

4.
Biancardi V, Bicego K, Almeida M, Gargaglioni L . Locus coeruleus noradrenergic neurons and CO2 drive to breathing. Pflugers Arch. 2007; 455(6):1119-28. DOI: 10.1007/s00424-007-0338-8. View

5.
Nattie E, Li A . Muscimol dialysis into the caudal aspect of the Nucleus tractus solitarii of conscious rats inhibits chemoreception. Respir Physiol Neurobiol. 2008; 164(3):394-400. PMC: 4793890. DOI: 10.1016/j.resp.2008.09.004. View